(Q38537741)

3 September 2017

Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study (English)

1 reference

3 September 2017

Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma.A southwest oncology group study (English)

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

11 November 2022

1 reference

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

11 November 2022

author name string

Byrne GE Jr

8

1 reference

3 September 2017

Coltman CA Jr

12

1 reference

3 September 2017

S. E. Jones

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A84706

11 November 2022

P. N. Grozea

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A84706

11 November 2022

E. N. Metz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A84706

11 November 2022

A. Haut

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A84706

11 November 2022

R. L. Stephens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A84706

11 November 2022

F. S. Morrison

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A84706

11 November 2022

J. J. Butler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A84706

11 November 2022

G. E. Byrne

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A84706

11 November 2022

T. E. Moon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A84706

11 November 2022

R. Fisher

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A84706

11 November 2022

C. L. Haskins

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A84706

11 November 2022

C. A. Coltman

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A84706

11 November 2022

language of work or name

English

0 references

publication date

1 February 1979

1 reference

full work available at URL

3 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

11 November 2022

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

11 November 2022

1 reference

3 September 2017

43

1 reference

3 September 2017

417-425

1 reference

3 September 2017

2

1 reference

Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma

3 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197902%2943%3A2%3C417%3A%3AAID-CNCR2820430203%3E3.0.CO%3B2-I

Combination chemotherapy of lymphomas other than Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197902%2943%3A2%3C417%3A%3AAID-CNCR2820430203%3E3.0.CO%3B2-I

21 January 2018

1

61

1057

Anderson

1977

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

11 November 2022

2

61

935

Byrne

1977

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

Recent trends in the treatment of non-Hodgkin's lymphomas

11 November 2022

3

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

11 November 2022

4

31

1860

Carbone

1971

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

11 November 2022

5

61

1067

Coltman

1977

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

11 November 2022

7

61

945

Dorfman

1977

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

11 November 2022

8

61

1085

Durant

1977

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

11 November 2022

9

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

11 November 2022

10

61

1009

Herman

1977

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

Histopathologic review of lymphoma cases from the southwest oncology group

11 November 2022

13

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

Nonparametric Estimation from Incomplete Observations

11 November 2022

14

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

11 November 2022

15

61

971

Lukes

1977

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

11 November 2022

16

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in advanced non-Hodgkin's lymphomas

11 November 2022

17

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases

11 November 2022

19

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

Combination chemotherapy of advanced lymphocytic lymphoma:Importance of histologic classification in evaluating response

11 November 2022

22

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

Delay in Progression of Malignant Lymphoma after BCG Vaccination

11 November 2022

24

1 reference

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(197902)43:2%3C417::AID-CNCR2820430203%3E3.0.CO;2-I

11 November 2022

Identifiers

10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I

1 reference

3 September 2017

1 reference